British experts have warned against being overly optimistic about the new crown vaccine

Kate Bingham, chair of the British Vaccine Working Group, warned on the 28th that the first generation of the new coronavirus vaccine "may not be perfect" and people should not be overly optimistic.
The first generation of vaccines is likely to be imperfect, and we should be prepared that they may not prevent infection, but reduce symptoms, and even then, they may not be effective for everyone or in the long term, " Bingham said in a media interview.
Writing in The Lancet recently, Bingham argues that no vaccine in medical history "has been so eagerly awaited" and that "vaccination is widely regarded as the only strategy to address the current global epidemic", "but we have no idea whether there will be a truly effective vaccine, and we need to prevent indiscipstivity and over-optimism".
Bingham said: "The UK vaccine strategy is to create a diverse mix that spans different forms, ingesting the UK's best chance of getting a safe and effective vaccine.
we know and recognize a lot of information about vaccines, and we are not sure which vaccine will succeed."
George Eustice, the UK environment secretary, told the media that Mr Bingham's analysis was "probably correct" and that "vaccines will be the answer to some extent, but it is too early to say exactly when they will succeed."
, a british scientific community review of coronavirus vaccine research called for a standardized approach to assessing the effectiveness of all potential new coronary vaccinations.
Sanne Hodgson, of the University of Oxford in the UK, said: "Using a standardized approach to measuring the success of vaccines in clinical trials is important for meaningful controlled studies and the most effective candidates will be further promoted."
is understood to have more than 200 vaccine candidates being developed around the world, 44 of which are in clinical trials and 9 are in the third phase of clinical trial evaluation.
Gao Tianxuan Source: China News Network Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Mets Medical, and are not authorized to reproduce by any media, website or individual, and are authorized to be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
at the same time reproduced content does not represent the position of this site.
leave a message here